Synopsis
Synopsis
0
JDMF
0
VMF
0
Australia
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. Dichlofenal
2. Diclofenac
3. Diclofenac Sodium
4. Diclofenac, Sodium
5. Diclonate P
6. Diclophenac
7. Dicrofenac
8. Feloran
9. Gp 45,840
10. Gp-45,840
11. Gp45,840
12. Novapirina
13. Orthofen
14. Orthophen
15. Ortofen
16. Sodium Diclofenac
17. Sr 38
18. Sr-38
19. Sr38
20. Voltaren
21. Voltarol
1. 15307-81-0
2. Cataflam
3. Cgp 45840b
4. Voltfast
5. Cambia
6. Zipsor
7. Diclofenac Potassium [usan:usp]
8. Potassium Diclofenac
9. Potassium;2-[2-(2,6-dichloroanilino)phenyl]acetate
10. Diclofenac (potassium)
11. Cgp-45840b
12. Diclofenac Potassium Salt
13. L4d5ua6cb4
14. Chebi:4508
15. Benzeneacetic Acid, 2-((2,6-dichlorophenyl)amino)-, Monopotassium Salt
16. Potassium 2-(2-((2,6-dichlorophenyl)amino)phenyl)acetate
17. Cataflam; Diclofenac Potassium; K-fenak; Potassium Diclofenac; Prosorb
18. Diclofenac Potassium [usan]
19. Unii-l4d5ua6cb4
20. Cataflam (tn)
21. Potassium (o-(2,6-dichloroanilino)phenyl)acetate
22. Cambia (tn)
23. Zipsor (tn)
24. Diclofenac Potassium (usp)
25. Schembl40784
26. Chembl1200804
27. Dtxsid30165212
28. Hms3656d18
29. Diclofenac Potassium [vandf]
30. Diclofenac Potassium [mart.]
31. S3062
32. Diclofenac Potassium [usp-rs]
33. Diclofenac Potassium [who-dd]
34. Akos015889752
35. Akos015994733
36. Diclofenac Potassium Salt [mi]
37. Ccg-267848
38. Ks-5037
39. Ac-18735
40. Diclofenac Potassium [orange Book]
41. Hy-15038
42. Diclofenac Potassium [ep Monograph]
43. Db-043176
44. Diclofenac Potassium [usp Monograph]
45. Cs-0003712
46. Ft-0603076
47. Sw196404-4
48. D00903
49. Q27106401
50. Potassium {2-[(2,6-dichlorophenyl)amino]phenyl}acetate
51. Potassium 2-(2-(2,6-dichlorophenylamino)phenyl)acetate
52. Potassium (o-((2,6-dichlorophenyl)amino)phenyl)acetate
53. 2-((2,6-dichlorophenyl)amino)benzeneacetic Acid, Monopotassium Salt
Molecular Weight | 334.2 g/mol |
---|---|
Molecular Formula | C14H10Cl2KNO2 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 4 |
Exact Mass | 332.9725654 g/mol |
Monoisotopic Mass | 332.9725654 g/mol |
Topological Polar Surface Area | 52.2 Ų |
Heavy Atom Count | 20 |
Formal Charge | 0 |
Complexity | 310 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 8 | |
---|---|
Drug Name | Cambia |
Drug Label | CAMBIA (Diclofenac Potassium for Oral Solution) is a benzeneacetic acid derivative NSAID. CAMBIA is available as a buffered soluble powder, designed to be mixed with water prior to oral administration. CAMBIA is a white to off-white, buff... |
Active Ingredient | Diclofenac potassium |
Dosage Form | For solution |
Route | Oral |
Strength | 50mg |
Market Status | Prescription |
Company | Depomed |
2 of 8 | |
---|---|
Drug Name | Cataflam |
PubMed Health | Diclofenac |
Drug Classes | Analgesic, Anti-Inflammatory, Antimigraine, Antirheumatic, Central Nervous System Agent, Musculoskeletal Agent, Ophthalmologic Agent |
Drug Label | Cataflam (diclofenac potassium immediate-release tablets) is a benzeneacetic acid derivative. Cataflam is available as immediate-release tablets of 50 mg (light brown) for oral administration. The chemical name is 2-[(2,6-dichlorophenyl)amino] benz... |
Active Ingredient | Diclofenac potassium |
Dosage Form | Tablet |
Route | Oral |
Strength | 50mg |
Market Status | Prescription |
Company | Novartis |
3 of 8 | |
---|---|
Drug Name | Diclofenac potassium |
Drug Label | Diclofenac potassium tablets USP are a benzeneacetic acid derivative. Diclofenac potassium tablets USP, 50 mg are available as orange, film-coated tablets for oral administration. The chemical name is 2-[(2,6-dichlorophenyl)amino] benzeneacetic acid,... |
Active Ingredient | Diclofenac potassium |
Dosage Form | Tablet |
Route | Oral |
Strength | 50mg |
Market Status | Prescription |
Company | Teva; Apotex; Sandoz; Mylan |
4 of 8 | |
---|---|
Drug Name | Zipsor |
PubMed Health | Diclofenac |
Drug Classes | Analgesic, Anti-Inflammatory, Antimigraine, Antirheumatic, Central Nervous System Agent, Musculoskeletal Agent, Ophthalmologic Agent |
Drug Label | Zipsor (diclofenac potassium) Liquid Filled Capsule is a benzeneacetic acid derivative NSAID. Zipsor is available as liquid-filled capsules of 25 mg for oral administration. The chemical name is 2-[(2,6- dichlorophenyl) amino] benzeneacetic acid mono... |
Active Ingredient | Diclofenac potassium |
Dosage Form | Capsule |
Route | Oral |
Strength | 25mg |
Market Status | Prescription |
Company | Depomed |
5 of 8 | |
---|---|
Drug Name | Cambia |
Drug Label | CAMBIA (Diclofenac Potassium for Oral Solution) is a benzeneacetic acid derivative NSAID. CAMBIA is available as a buffered soluble powder, designed to be mixed with water prior to oral administration. CAMBIA is a white to off-white, buff... |
Active Ingredient | Diclofenac potassium |
Dosage Form | For solution |
Route | Oral |
Strength | 50mg |
Market Status | Prescription |
Company | Depomed |
6 of 8 | |
---|---|
Drug Name | Cataflam |
PubMed Health | Diclofenac |
Drug Classes | Analgesic, Anti-Inflammatory, Antimigraine, Antirheumatic, Central Nervous System Agent, Musculoskeletal Agent, Ophthalmologic Agent |
Drug Label | Cataflam (diclofenac potassium immediate-release tablets) is a benzeneacetic acid derivative. Cataflam is available as immediate-release tablets of 50 mg (light brown) for oral administration. The chemical name is 2-[(2,6-dichlorophenyl)amino] benz... |
Active Ingredient | Diclofenac potassium |
Dosage Form | Tablet |
Route | Oral |
Strength | 50mg |
Market Status | Prescription |
Company | Novartis |
7 of 8 | |
---|---|
Drug Name | Diclofenac potassium |
Drug Label | Diclofenac potassium tablets USP are a benzeneacetic acid derivative. Diclofenac potassium tablets USP, 50 mg are available as orange, film-coated tablets for oral administration. The chemical name is 2-[(2,6-dichlorophenyl)amino] benzeneacetic acid,... |
Active Ingredient | Diclofenac potassium |
Dosage Form | Tablet |
Route | Oral |
Strength | 50mg |
Market Status | Prescription |
Company | Teva; Apotex; Sandoz; Mylan |
8 of 8 | |
---|---|
Drug Name | Zipsor |
PubMed Health | Diclofenac |
Drug Classes | Analgesic, Anti-Inflammatory, Antimigraine, Antirheumatic, Central Nervous System Agent, Musculoskeletal Agent, Ophthalmologic Agent |
Drug Label | Zipsor (diclofenac potassium) Liquid Filled Capsule is a benzeneacetic acid derivative NSAID. Zipsor is available as liquid-filled capsules of 25 mg for oral administration. The chemical name is 2-[(2,6- dichlorophenyl) amino] benzeneacetic acid mono... |
Active Ingredient | Diclofenac potassium |
Dosage Form | Capsule |
Route | Oral |
Strength | 25mg |
Market Status | Prescription |
Company | Depomed |
Anti-Inflammatory Agents, Non-Steroidal
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)
Cyclooxygenase Inhibitors
Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes. (See all compounds classified as Cyclooxygenase Inhibitors.)
Certificate Number : R1-CEP 2007-144 - Rev 01
Status : Valid
Issue Date : 2022-06-17
Type : Chemical
Substance Number : 1508
Certificate Number : R0-CEP 2002-085 - Rev 01
Status : Withdrawn by Holder
Issue Date : 2004-11-02
Type : Chemical
Substance Number : 1508
Certificate Number : R1-CEP 2014-031 - Rev 00
Status : Valid
Issue Date : 2021-03-08
Type : Chemical
Substance Number : 1508
Certificate Number : CEP 2021-137 - Rev 01
Status : Valid
Issue Date : 2024-05-06
Type : Chemical
Substance Number : 1508
Certificate Number : R0-CEP 2010-133 - Rev 01
Status : Withdrawn by Holder
Issue Date : 2013-10-03
Type : Chemical
Substance Number : 1508
Certificate Number : R1-CEP 2010-286 - Rev 04
Status : Valid
Issue Date : 2022-03-24
Type : Chemical
Substance Number : 1508
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Regulatory Info :
Registration Country : Sweden
Brand Name : Inst Antin
Dosage Form : POWDER FOR ORAL SOLUTION IN SACHET
Dosage Strength : 50 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : Diclofenac T Actavis
Dosage Form : FILM COATED PILL
Dosage Strength : 25 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : Kappadi
Dosage Form : FILM COATED PILL
Dosage Strength : 50 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : Kappadi
Dosage Form : FILM COATED PILL
Dosage Strength : 25 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Switzerland
Brand Name : Voltaren Rapid
Dosage Form : Drag
Dosage Strength : 50mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Switzerland
Brand Name : Voltaren Rapid
Dosage Form : Drag
Dosage Strength : 50mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Sweden
Brand Name : Diclofenac T Orifarm
Dosage Form : FILM COATED PILL
Dosage Strength : 25 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : Diclofenac T ratiopharm
Dosage Form : FILM COATED PILL
Dosage Strength : 25 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : Diclofenac T ratiopharm
Dosage Form : FILM COATED PILL
Dosage Strength : 50 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Switzerland
Brand Name : Inflamac rapid
Dosage Form : Film-Coated Tablets
Dosage Strength : 50mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
A Diclofenac Potassium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Diclofenac Potassium, including repackagers and relabelers. The FDA regulates Diclofenac Potassium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Diclofenac Potassium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Diclofenac Potassium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Diclofenac Potassium supplier is an individual or a company that provides Diclofenac Potassium active pharmaceutical ingredient (API) or Diclofenac Potassium finished formulations upon request. The Diclofenac Potassium suppliers may include Diclofenac Potassium API manufacturers, exporters, distributors and traders.
click here to find a list of Diclofenac Potassium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Diclofenac Potassium DMF (Drug Master File) is a document detailing the whole manufacturing process of Diclofenac Potassium active pharmaceutical ingredient (API) in detail. Different forms of Diclofenac Potassium DMFs exist exist since differing nations have different regulations, such as Diclofenac Potassium USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Diclofenac Potassium DMF submitted to regulatory agencies in the US is known as a USDMF. Diclofenac Potassium USDMF includes data on Diclofenac Potassium's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Diclofenac Potassium USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Diclofenac Potassium suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Diclofenac Potassium Drug Master File in Korea (Diclofenac Potassium KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Diclofenac Potassium. The MFDS reviews the Diclofenac Potassium KDMF as part of the drug registration process and uses the information provided in the Diclofenac Potassium KDMF to evaluate the safety and efficacy of the drug.
After submitting a Diclofenac Potassium KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Diclofenac Potassium API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Diclofenac Potassium suppliers with KDMF on PharmaCompass.
A Diclofenac Potassium CEP of the European Pharmacopoeia monograph is often referred to as a Diclofenac Potassium Certificate of Suitability (COS). The purpose of a Diclofenac Potassium CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Diclofenac Potassium EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Diclofenac Potassium to their clients by showing that a Diclofenac Potassium CEP has been issued for it. The manufacturer submits a Diclofenac Potassium CEP (COS) as part of the market authorization procedure, and it takes on the role of a Diclofenac Potassium CEP holder for the record. Additionally, the data presented in the Diclofenac Potassium CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Diclofenac Potassium DMF.
A Diclofenac Potassium CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Diclofenac Potassium CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Diclofenac Potassium suppliers with CEP (COS) on PharmaCompass.
A Diclofenac Potassium written confirmation (Diclofenac Potassium WC) is an official document issued by a regulatory agency to a Diclofenac Potassium manufacturer, verifying that the manufacturing facility of a Diclofenac Potassium active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Diclofenac Potassium APIs or Diclofenac Potassium finished pharmaceutical products to another nation, regulatory agencies frequently require a Diclofenac Potassium WC (written confirmation) as part of the regulatory process.
click here to find a list of Diclofenac Potassium suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Diclofenac Potassium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Diclofenac Potassium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Diclofenac Potassium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Diclofenac Potassium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Diclofenac Potassium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Diclofenac Potassium suppliers with NDC on PharmaCompass.
Diclofenac Potassium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Diclofenac Potassium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Diclofenac Potassium GMP manufacturer or Diclofenac Potassium GMP API supplier for your needs.
A Diclofenac Potassium CoA (Certificate of Analysis) is a formal document that attests to Diclofenac Potassium's compliance with Diclofenac Potassium specifications and serves as a tool for batch-level quality control.
Diclofenac Potassium CoA mostly includes findings from lab analyses of a specific batch. For each Diclofenac Potassium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Diclofenac Potassium may be tested according to a variety of international standards, such as European Pharmacopoeia (Diclofenac Potassium EP), Diclofenac Potassium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Diclofenac Potassium USP).
LOOKING FOR A SUPPLIER?